2m 2m 2m 2m 2m 2m 2m
Intellia Therape (NTLA)
NASDAQ
$13.16+$0.14 (+1.05%)
Price as of Jul 14, 2026 4:33 AM EDT- $2.0BMarket Cap
- 8.95%1-Year Change
- BiotechnologyIndustry
Intellia Therape (NTLA)
$13.16+$0.14 (+1.05%)
Earnings Score
Valuation | NTLA | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | NTLA | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -12.04% | ||
12-Month Momentum | 5.77% | ||
3-Month Risk Adjusted Momentum | -34.88% | ||
12-Month Risk Adjusted Momentum | 6.11% |
True Yield
Valuation | NTLA | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | NTLA | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 2 |